iTeos Therapeutics' (ITOS) CEO Michel Detheux on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 05/14/21
iTeos Reports First Quarter 2021 Financial Results and Provides Business UpdateGlobeNewsWire • 05/13/21
iTeos to Report First Quarter 2021 Financial Results and Provide Corporate Update on May 13, 2021GlobeNewsWire • 05/06/21
iTeos Therapeutics Announces New Preliminary Data Indicating Clinical Activity with its Anti-TIGIT Antibody, EOS-448, at the AACR Annual Meeting 2021GlobeNewsWire • 04/10/21
iTeos Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business UpdateGlobeNewsWire • 03/24/21
iTeos Reports Third Quarter 2020 Financial Results and Provides Business UpdateGlobeNewsWire • 11/12/20